Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVALT12: paclitaxel + carboplatin + bevacizumab with or without nitroglycerin patches in stage IV non-squamous NSCLC
2010-022104-50Phase 2Active
- Sponsor
- NVALT
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of nitroglycerin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by NVALT. Primary endpoint: Progression-free survival. Started Jul 2010; status: active.
02
Drugs
nitroglycerin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2010-022104-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022104-50.